Treace Medical Concepts, Inc. (NASDAQ:TMCI – Get Free Report) shares were up 2.8% during mid-day trading on Monday . The stock traded as high as $17.01 and last traded at $17.00. Approximately 62,683 shares were traded during trading, a decline of 84% from the average daily volume of 388,832 shares. The stock had previously closed […]
Treace Medical Concepts (NASDAQ:TMCI – Free Report) had its target price lowered by Stephens from $27.00 to $25.00 in a report issued on Thursday morning, Marketbeat.com reports. The firm currently has an equal weight rating on the stock. Several other brokerages have also recently issued reports on TMCI. Truist Financial dropped their price objective on […]
Treace Medical Concepts, Inc. (NASDAQ:TMCI – Get Rating) Director F Barry Bays sold 48,503 shares of Treace Medical Concepts stock in a transaction on Friday, June 2nd. The stock was sold at an average price of $26.51, for a total transaction of $1,285,814.53. Following the transaction, the director now directly owns 1,042,318 shares of the […]
Treace Medical Concepts, Inc. (NASDAQ:TMCI – Get Rating) Director F Barry Bays sold 1,042,318 shares of the firm’s stock in a transaction that occurred on Monday, June 5th. The stock was sold at an average price of $26.51, for a total transaction of $27,631,850.18. The sale was disclosed in a legal filing with the SEC, […]
Sectoral Asset Management Inc. trimmed its holdings in Treace Medical Concepts, Inc. (NASDAQ:TMCI – Get Rating) by 26.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 179,924 shares of the company’s stock after selling 63,750 shares during the period. […]